Skip to Main Content

Author Details

Jessica L Smith
Vaccine and Gene Therapy Institute, Oregon Health and Science University
2005
36
23
PMIDPaper TitleJournal TitlePublished Year
36682515Blood-brain barrier penetration of non-replicating SARS-CoV-2 and S1 variants of concern induce neuroinflammation which is accentuated in a mouse model of Alzheimer's disease.Brain Behav Immun2023
35172138Balanced T and B cell responses are required for immune protection against Powassan virus in virus-like particle vaccination.Cell Rep2022
35755126Titration and neutralizing antibody quantification by focus forming assay for Powassan virus.STAR Protoc2022
35487969A lyophilized colorimetric RT-LAMP test kit for rapid, low-cost, at-home molecular testing of SARS-CoV-2 and other pathogens.Sci Rep2022
33835811Targeting Chikungunya Virus Replication by Benzoannulene Inhibitors.J Med Chem2021
32367359Analysis of Serum Anti-Zika Virus Antibodies by Focus Reduction Neutralization Test.Methods Mol Biol2020
31935257A neonatal nonhuman primate model of gestational Zika virus infection with evidence of microencephaly, seizures and cardiomyopathy.PLoS One2020
32117091The E3 Ubiquitin Ligase SIAH1 Targets MyD88 for Proteasomal Degradation During Dengue Virus Infection.Front Microbiol2020
31165049Structural Determinants of the APOBEC3G N-Terminal Domain for HIV-1 RNA Association.Front Cell Infect Microbiol2019
31413072Risk of Zika microcephaly correlates with features of maternal antibodies.J Exp Med2019
29343712Zika virus infection in pregnant rhesus macaques causes placental dysfunction and immunopathology.Nat Commun2018
30347144Impact of Dengue Virus Serotype 2 Strain Diversity on Serological Immune Responses to Dengue.ACS Infect Dis2018
29577083Human Antibody Responses to Emerging Mayaro Virus and Cocirculating Alphavirus Infections Examined by Using Structural Proteins from Nine New and Old World Lineages.mSphere2018
29709563Characterization and structure-activity relationship analysis of a class of antiviral compounds that directly bind dengue virus capsid protein and are incorporated into virions.Antiviral Res2018
28465426A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses.mBio2017
28228395Antibody Responses to Zika Virus Infections in Environments of Flavivirus Endemicity.Clin Vaccine Immunol2017
28302150Identification of a tripartite interaction between the N-terminus of HIV-1 Vif and CBFβ that is critical for Vif function.Retrovirology2017
28278237Zika Virus infection of rhesus macaques leads to viral persistence in multiple tissues.PLoS Pathog2017
28380070Correction: Zika Virus infection of rhesus macaques leads to viral persistence in multiple tissues.PLoS Pathog2017
28148804A MicroRNA Screen Identifies the Wnt Signaling Pathway as a Regulator of the Interferon Response during Flavivirus Infection.J Virol2017
26646986Characterization of a Novel Human-Specific STING Agonist that Elicits Antiviral Activity Against Emerging Alphaviruses.PLoS Pathog2015
24599995Inhibition of dengue virus replication by a class of small-molecule compounds that antagonize dopamine receptor d4 and downstream mitogen-activated protein kinase signaling.J Virol2014
24942576HIV-1 and HIV-2 Vif interact with human APOBEC3 proteins using completely different determinants.J Virol2014
23097438APOBEC3G restricts HIV-1 to a greater extent than APOBEC3F and APOBEC3DE in human primary CD4+ T cells and macrophages.J Virol2013
23824813Flaviviruses are sensitive to inhibition of thymidine synthesis pathways.J Virol2013
22345437Induction of the cellular microRNA, Hs_154, by West Nile virus contributes to virus-mediated apoptosis through repression of antiapoptotic factors.J Virol2012
21795337Inhibition of dengue virus infections in cell cultures and in AG129 mice by a small interfering RNA targeting a highly conserved sequence.J Virol2011
20668078P body-associated protein Mov10 inhibits HIV-1 replication at multiple stages.J Virol2010
20973722High-content assay to identify inhibitors of dengue virus infection.Assay Drug Dev Technol2010
20943965Identification of specific determinants of human APOBEC3F, APOBEC3C, and APOBEC3DE and African green monkey APOBEC3F that interact with HIV-1 Vif.J Virol2010
19036809Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif.J Virol2009
19837465Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development.Trends Pharmacol Sci2009
18667513Caveolin-1-dependent infectious entry of human papillomavirus type 31 in human keratinocytes proceeds to the endosomal pathway for pH-dependent uncoating.J Virol2008
18834609Virus activated filopodia promote human papillomavirus type 31 uptake from the extracellular matrix.Virology2008
17626097Human papillomavirus type 31 uses a caveolin 1- and dynamin 2-mediated entry pathway for infection of human keratinocytes.J Virol2007
15890923Human papillomavirus type 31b infection of human keratinocytes does not require heparan sulfate.J Virol2005
  • 1 - 36 of 36

Recommended Authors

Stanford University School of Medicine
Career Start Year 2013
Number of shared co-authors 0
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year 2012
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 2012
Number of shared co-authors 0
Indian Institute of Science
Career Start Year 2011
Number of shared co-authors 1
University of Texas Medical Branch
Career Start Year 2010
Number of shared co-authors 0
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2010
Number of shared co-authors 0
Sidney Kimmel Medical College, Thomas Jefferson University
Career Start Year 2009
Number of shared co-authors 0
Institut Pasteur, CNRS UMR 3569
Career Start Year 2009
Number of shared co-authors 0
Northwestern University Feinberg School of Medicine
Career Start Year 2008
Number of shared co-authors 1
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 2
Gladstone Institutes
Career Start Year 2007
Number of shared co-authors 0
Institute of Tropical Medicine
Career Start Year 2007
Number of shared co-authors 0
Rutgers University
Career Start Year 2007
Number of shared co-authors 0
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year 2003
Number of shared co-authors 1
Duke-NUS Medical School
Career Start Year 2003
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 2002
Number of shared co-authors 0
University of California davis
Career Start Year 2002
Number of shared co-authors 0
Washington University School of Medicine at St. Louis
Career Start Year 2000
Number of shared co-authors 0
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 1997
Number of shared co-authors 3
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 1
University of Edinburgh
Career Start Year 1996
Number of shared co-authors 1
University of Texas Medical Branch
Career Start Year 1996
Number of shared co-authors 3
University of Massachusetts Medical School
Career Start Year 1995
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 3
The Rockefeller University
Career Start Year 1993
Number of shared co-authors 2
Boston University
Career Start Year 1991
Number of shared co-authors 0
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year 1987
Number of shared co-authors 2
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 13
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 0

Collaborators

Vaccine & Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 19
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 8
Oregon Health and Science University
Co-authored papers 7
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 7
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 5
The University of New Mexico School of Medicine
Co-authored papers 4
College of Veterinary Medicine, Oregon State University
Co-authored papers 4
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 3
Memorial Sloan Kettering Cancer Center, USA Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Co-authored papers 2
Oregon Health & Science University
Co-authored papers 2
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 1
Frederick National Laboratory for Cancer Research
Co-authored papers 1
University of North Carolina at Chapel Hill.
Co-authored papers 1
Rockefeller University
Co-authored papers 1
Graduate School of Medicine, Kyoto University
Co-authored papers 1
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 1
J. Craig Venter Institute
Co-authored papers 1
University of Colorado Anschutz Medical Campus
Co-authored papers 1
The Francis Crick Institute
Co-authored papers 1
Earle A. Chiles Research Institute, Providence Cancer Institute
Co-authored papers 1
The Rockefeller University
Co-authored papers 1
Oregon Health & Science University
Co-authored papers 1
The Roslin Institute, The University of Edinburgh
Co-authored papers 1
Oregon Health & Science University, University of California Berkeley
Co-authored papers 1
University of North Carolina School of Medicine
Co-authored papers 1
Instituto Goncalo Moniz, Yale School of Public Health
Co-authored papers 1
Oregon Health & Science University
Co-authored papers 1
University of Arizona Center on Aging, University of Arizona
Co-authored papers 1
Federal University of Sao Paulo
Co-authored papers 1